Radioligand Therapy Market
Radioligand Therapy Market Size, Share, Growth & Industry Analysis, By Product Type (Approved Products, Pipeline Products), By Biomarker (Prostate-Specific Membrane Antigen, Cytochrome P450 17A1 Inhibitor, Ki-67 Expression and Grading), By End User (Hospitals, Clinics, Academic & Research Institutes, Others) and Regional Analysis, 2024-2031
Pages : 120
Base Year : 2023
Release : April 2024
Report ID: KR681
Snapshot
Base Year
2023
Forecast Year
2024-2031
Historical Years
2019-2022
Market Value (2023)
USD 11.21 Billion
Forecasted Value (2031)
USD 16.25 Billion
CAGR (2024 - 2031)
4.94%
Fastest Growing Region (2024 - 2031)
Asia Pacific
Largest Region
North America
Market Scope
By Product Type
Approved Products, Pipeline Products
By Biomarker
Prostate-Specific Membrane Antigen, Cytochrome P450 17A1 Inhibitor, Ki-67 Expression and Grading
